Veracyte Correlations

VCYT Stock  USD 36.19  1.33  3.82%   
The current 90-days correlation between Veracyte and Kiniksa Pharmaceuticals is 0.24 (i.e., Modest diversification). The correlation of Veracyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Veracyte Correlation With Market

Good diversification

The correlation between Veracyte and DJI is -0.19 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and DJI in the same portfolio, assuming nothing else is changed.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Veracyte. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.

Moving together with Veracyte Stock

  0.65KURA Kura OncologyPairCorr

Moving against Veracyte Stock

  0.35RNAZ Transcode TherapeuticsPairCorr
  0.59CVX Chevron CorpPairCorr
  0.47SHG Shinhan Financial Earnings Call This WeekPairCorr
  0.44KB KB Financial Group Earnings Call This WeekPairCorr
  0.42DBVT DBV TechnologiesPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LEGNZLAB
IDYASRRK
FOLDSRRK
SRRKKNSA
APLSSRRK
IRONLEGN
  

High negative correlations

FOLDIRON
SRRKZLAB
FOLDLEGN
SRRKLEGN
ZLABKNSA
FOLDZLAB

Risk-Adjusted Indicators

There is a big difference between Veracyte Stock performing well and Veracyte Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Veracyte's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
KNSA  1.67  0.19  0.07  0.53  2.00 
 3.33 
 10.07 
ZLAB  1.94 (0.63) 0.00 (0.85) 0.00 
 4.75 
 10.32 
LEGN  2.33 (0.91) 0.00 (19.67) 0.00 
 3.83 
 19.65 
SRRK  3.07  0.76  0.26  0.81  2.52 
 7.07 
 31.68 
IRON  2.07 (0.08) 0.00 (0.31) 0.00 
 4.33 
 14.87 
TARS  1.69 (0.16) 0.00 (0.14) 0.00 
 3.92 
 12.48 
IDYA  1.99  0.00 (0.01) 0.08  2.26 
 4.86 
 10.56 
APLS  2.50  0.19  0.05  0.35  3.57 
 5.01 
 25.67 
FOLD  1.52  0.75  0.67  1.76  0.00 
 3.45 
 30.77 
ADPT  3.19 (0.06) 0.00 (0.10) 0.00 
 9.94 
 29.55 

Veracyte Corporate Management

Robert BraininExecutive OfficerProfile
John LeiteChief BusinessProfile
Annie McGuireSr CounselProfile
Tracy MorrisVP CommunicationsProfile